PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 23 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Crude extracts from pods, seeds, or leaves demonstrated prominent anti-inflammatory and antinociceptive actions in rodents [PMID:12860302]
Isolated compounds 2, 3, and 9 from the fruits exhibited significant inhibitory activity against the alpha-glucosidase enzyme [PMID:33445612]
Pinoresinol and vanillic acid increased the proliferation of C2C12 mouse myoblast cells without cytotoxicity [PMID:36080161]
Aqueous extracts and fractions of fruits were evaluated for anti-cancer activity in HT29 and HCT166 cell lines [PMID:41009020]
Evidence summary
PubMed sources
- 1.PMID: 36013410 (2022) — Effects of Different Growth Regulators on the Rooting of Catalpa bignonioides Softwood Cuttings. · Life (Basel, Switzerland)
- 2.PMID: 36616550 (2022) — Extraction and Characterization of New Cellulosic Fiber from Catalpa bignonioides Fruits for Potential Use in Sustainable Products. · Polymers
- 3.PMID: 17604916 (2007) — Antioxidant activity of Catalpa bignonioides. · Fitoterapia
- 4.PMID: 30708679 (2014) — First Report of Powdery Mildew Caused by Erysiphe elevata on Catalpa bignonioides in Korea. · Plant disease
- 5.PMID: 33445612 (2021) — The Chemical Constituents from Fruits of Catalpa bignonioides Walt. and Their α-Glucosidase Inhibitory Activity and Insulin Secretion Effect.